EFFECTIVENESS AND SAFETY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB FORMULATION IN INFLAMMATORY BOWEL DISEASE PATIENTS IN CLINICAL REMISSION

Laura Parisio  ¹     Carlo Romano Settanni     Daniele Napolitano     Simone Varca     Elisa Schiavoni     Lucrezia Laterza     Loris Riccardo Lopetuso  ²     Marco Pizzoferrato     Stefano Bibbò     Norma Alfieri     Luisa Guidi     Alfredo Papa  ³     Antonio Gasbarrini     Alessandro Armuzzi  ⁴     Daniela Pugliese     Franco Scaldaferri    
¹ Fondazione Policlinico Gemelli, IRCCS, Rome, Italy
² University of Chieti-Pescara "G. d'Annunzio", Chieti, Italy
³ Università Cattolica del S. Cuore, Roma, Italy
⁴ Humanitas University, IBD Center, IRCCS Humanitas Research Hospital, Pieve Emanuele, Milan, Italy

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)